Branstetter, Lee, Chatterjee, Chirantan and Higgins, Matthew (2022) Generic competition and the incentives for early-stage pharmaceutical innovation. Research Policy, 51 (10). ISSN 0048-7333

PDF - Accepted Version Restricted to SRO admin only until 6 February 2024. Download (1MB)

Abstract

What impact has rising generic competition had on the nature and direction of pharmaceutical innovation? We find broad-based, strong evidence that pharmaceutical companies have diverted their new drug development efforts away from therapeutic markets already well-served by generic drugs. We also find that increasing generic competition induces firms to shift their R&D activity towards more biologic-based products and away from chemical-based products. We conclude by discussing potential implications of our results for long-run innovation policy.

Item Type:	Article
Schools and Departments:	University of Sussex Business School > SPRU - Science Policy Research Unit
SWORD Depositor:	Mx Elements Account
Depositing User:	Mx Elements Account
Date Deposited:	27 Jul 2022 09:16
Last Modified:	09 Aug 2022 13:00
URI:	http://sro.sussex.ac.uk/id/eprint/107130

View download statistics for this item

📧 Request an update